AI is only as good as the data it learns from. Right now, research suggests 73% of health data in AI comes from North America, South America and Europe. But those regions only make up around 22% of ...
A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...
Melissa Chambers has had a remarkable journey to founding cybersecurity company Sitehop. She tells Fiona Haran why she could write a book on resilience “Don’t tell me I can’t do something - because ...
Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...
An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...
A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant detection, megabase-scale phasing, and improved resolution of paralogous ...
To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...
Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...
This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...
Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...
A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results